Representative Dean Phillips Stocks

VPOfficerCEODirectorChairmanFounderPresidentExecutiveMoney ManagerElective Official
On August 13, 2022, Representative Dean Phillips of US Congress acquired under $15k worth of Abbott Laboratories's common stock. Such disclosures are part of transparency measures that require elected officials to report their investments, ensuring public awareness and preventing conflicts of interest. Below are 25 other transactions of Dean Phillips.
2022-08-13Acquired Under $15KABT Abbott LaboratoriesInsidersVerify
2021-08-13Acquired Under $15KAZN AstraZeneca PLC ADRInsidersVerify
2021-02-13Acquired Under $15KT ATT IncInsidersVerify
2021-01-09Acquired Under $15KT ATT IncInsidersVerify
2020-12-11Acquired Under $15KMU Micron TechnologyInsidersVerify
2020-11-11Acquired Under $15KMU Micron TechnologyInsidersVerify
2020-10-09Acquired Under $15KMMM 3M CompanyInsidersVerify
2020-09-11Acquired Under $15KTDG Transdigm GroupInsidersVerify
2020-08-09Acquired Under $15KTFC Truist Financial CorpInsidersVerify
2020-07-07Acquired Under $15KPGR Progressive CorpInsidersVerify
2020-06-15Acquired Under $15KMMM 3M CompanyInsidersVerify
2020-05-07Acquired Under $15KMMM 3M CompanyInsidersVerify
2020-04-10Acquired Under $15KCMCSA Comcast CorpInsidersVerify
2020-03-12Acquired $15K to $50KMMM 3M CompanyInsidersVerify
2020-02-07Acquired Under $15KWFC Wells FargoInsidersVerify
2020-01-09Acquired Under $15KCMCSA Comcast CorpInsidersVerify
2019-12-11Acquired Under $15KBKNG Booking HoldingsInsidersVerify
2019-11-06Acquired Under $15KSCHW Charles Schwab CorpInsidersVerify
2019-10-11Acquired Under $15KANET Arista NetworksInsidersVerify
2019-09-16Acquired Under $15KMMM 3M CompanyInsidersVerify
2019-07-11Acquired Under $15KMMM 3M CompanyInsidersVerify
2019-06-13Acquired Under $15KT ATT IncInsidersVerify
2019-04-16Acquired Under $15KMMM 3M CompanyInsidersVerify
2019-03-21Acquired Under $15KCAH Cardinal HealthInsidersVerify
2019-02-18Acquired Under $15KMMM 3M CompanyInsidersVerify
View All Elective Officials  

Risk-return Landscape of Dean Phillips's positions

  Expected Return   
       Risk  

Assets Rated by Market Efficiency

Many investors optimize their portfolios to maintain a risk-return balance that meets their personal investing preferences and liquidity needs. Understanding the relationship between the Sharpe ratio, risk, and expected return will help you build an optimal portfolio from your selected positions. Below are the essential efficiency ratios that can help you quickly create a reliable input to your portfolio optimization process.
EfficiencyMarket RiskExp ReturnPrice
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY